Urology
Volume 64, Issue 2 , Pages 317-322, August 2004

Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening☆

  • Steven E Oliver

      Affiliations

    • Department of Health Sciences, University of York and Hull York Medical School, York, United Kingdom
    • Corresponding Author InformationReprint requests: Steven E. Oliver, Ph.D., M.R.C.P., M.F.P.H.M., Department of Health Sciences, University of York and Hull York Medical School, Seebohm Rowntree Building, Heslington, York YO10 5DD, United Kingdom
    • ,
  • Jeff Holly

      Affiliations

    • Division of Surgery, University of Bristol, Bristol Royal Infirmary, Bristol, United Kingdom
    • ,
  • Tim J Peters

      Affiliations

    • Division of Primary Health Care, University of Bristol, Bristol, United Kingdom
    • ,
  • Jenny Donovan

      Affiliations

    • Department of Social Medicine, University of Bristol, Bristol, United Kingdom
    • ,
  • Raj Persad

      Affiliations

    • Division of Surgery, University of Bristol, Bristol Royal Infirmary, Bristol, United Kingdom
    • ,
  • David Gillatt

      Affiliations

    • Bristol Urological Institute, Southmead Hospital, Bristol, United Kingdom
    • ,
  • Anya Pearce

      Affiliations

    • Division of Surgery, University of Bristol, Bristol Royal Infirmary, Bristol, United Kingdom
    • ,
  • Freddie C Hamdy

      Affiliations

    • Academic Urology Unit, Division of Clinical Sciences, University of Sheffield, Sheffield, United Kingdom
    • ,
  • David E Neal

      Affiliations

    • Oncology Centre, Addenbrooke's Hospital, Cambridge, United Kingdom
    • ,
  • David Gunnell

      Affiliations

    • Department of Social Medicine, University of Bristol, Bristol, United Kingdom

Received 17 June 2003; accepted 9 March 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This research was funded by NHS South and West R&D; and the ProtecT treatment trial was funded by the NHS Health Technology Assessment Programme.

PII: S0090-4295(04)00335-8

doi:10.1016/j.urology.2004.03.018

Urology
Volume 64, Issue 2 , Pages 317-322, August 2004

Article Tools

* Image Usage & Resolution